Outcomes and side effects after first-line treatment with combination therapies for kidney cancer
This report looked at the results from 4 studies comparing [...]
This report looked at the results from 4 studies comparing [...]
This study looked at the survival of patients following partial [...]
This phase 2 study looked at the use of stereotactic [...]
Non-clear cell RCC is about 20-25% of all RCC diagnoses [...]
KEYNOTE-427 is an open-label, single-arm, phase II study to look [...]
The use of two medicines together (combination therapies) for previously [...]
Cancer Research UK has reported that over the past 6 [...]
Adjuvant therapy is medication that is given in addition to [...]
The latest findings from five studies presented at the ESMO [...]
Kidney cancers frequently have mutations in the von Hippel-Lindau (VHL) [...]